Table 10.

Series of meningiomas and respective percentages of AR expression.

Authors, year, country	AR %	Observations
Current paper	6.5	96 grade I
Carrol et al., 1995, USA (93)	67.0	39 grades I, II and III
Chen and Chen, 2001, China (92)	31.0	19 grade I
Konstantinidou et al., 2003, Greece (82)	28.6	39 grades I, II, and III
Korhonen et al., 2006, Finland (11)	40.3	47 grade I primary tumors. No relation to recurrent tumors
Kärjä et al., 2010, Finland /Sweden (13)		59 grade I. Primary, 32.3 ± 2.5%; recurrent, 32.4 ± 2.4%; p = 0.881
Leães et al., 2010, Brazil (86)	18.0	126 grades I, II, and III. No differences observed between subtypes

AR, androgen receptor.